PRISM BioLab (206A) · RiskRestated
Suspension of an Outsourced Service Provider and the Safety and Quality of Raw Materials
First written in FY2024. 1 of 2 entries say "Restated". Latest entry: FY2025.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Composite Risk Relating to Product Development, Supply Interruptions, and Product SafetyA theme 8 companies write about · 8 as a headwind · 0 as a tailwind
5 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「Facilities operated by our contractors may be closed or operations may be suspended due to technical problems, suspension of the supply of raw materials, pandemics such as COVID-19 and influenza, fires, earthquakes or other disasters.」
The risks relating to contractor suspensions, raw material supply, safety and quality, along with the policy of addressing them through multiple contractors and suppliers, were reiterated. - FY2024First statedAnnual report
「Facilities operated by our contractors may be closed or operations may be suspended due to technical problems, suspension of the supply of raw materials, pandemics such as COVID-19 and influenza, fires, earthquakes or other disasters.」
The company states that it will address the risk of interruptions to supply and research data by establishing arrangements with multiple contractors and suppliers.